Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose of oral midazolam for preoperative sedation in children
ChiCTR2300078404Phase 4Completed
- Sponsor
- Qingdao Women and Children’s Hospital
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of midazolam (3 arms), sponsored by Qingdao Women and Children’s Hospital. Primary endpoints: 5-point facial hedonic scale score, Ramsay scale score and 2 more. Started Jun 2022; status: completed.
02
Drugs
midazolam
Beyond the preview
Go deeper on ChiCTR2300078404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078404.